Absci (ABSI) Non Operating Income (2020 - 2026)
Absci's (ABSI) quarterly Non Operating Income came in at $1.3 million in Q1 2026, down 8.27% year-on-year from $1.4 million in Q1 2025, and down 6.02% quarter-over-quarter from $1.3 million in Q4 2025.
Absci (ABSI) Non Operating Income (2020 - 2026) Analysis & Trends
Absci has disclosed Non Operating Income across 7 years of filings, most recently posting $1.3 million for Q1 2026.
- Non Operating Income for Q1 2026 came in at $1.3 million, down 8.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.1 million (down 14.06% YoY), and the FY2025 annual result was $5.4 million, down 15.66% from the prior year.
- Non Operating Income came in at $1.3 million for Q1 2026 at Absci, down from $1.3 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $2.1 million in Q2 2024 to a low of -$70000.0 in Q1 2022.
- The 5-year median for Non Operating Income is $1.3 million (2025), against an average of $1.1 million.
- Across the five-year window, Non Operating Income tumbled 142.68% in 2022 and surged 1724.29% in 2023, its largest moves.
- Absci's Non Operating Income stood at $1.4 million in 2022, then plunged by 69.06% to $436000.0 in 2023, then soared by 111.24% to $921000.0 in 2024, then jumped by 46.15% to $1.3 million in 2025, then slipped by 6.02% to $1.3 million in 2026.
- The last three Non Operating Income figures came in at $1.3 million (Q1 2026), $1.3 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - | 1.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.27 Mn |
| Dec 31, 2025 | 1.35 Mn |
| Sep 30, 2025 | 1.55 Mn |
| Jun 30, 2025 | 955,000.00 |
| Mar 31, 2025 | 1.38 Mn |
| Dec 31, 2024 | 921,000.00 |
| Sep 30, 2024 | 1.53 Mn |
| Jun 30, 2024 | 2.12 Mn |
| Mar 31, 2024 | 1.71 Mn |
| Dec 31, 2023 | 436,000.00 |
| Sep 30, 2023 | 1.57 Mn |
| Jun 30, 2023 | 1.58 Mn |
| Mar 31, 2023 | 1.14 Mn |
| Dec 31, 2022 | 1.41 Mn |
| Sep 30, 2022 | 396,000.00 |
| Jun 30, 2022 | 148,000.00 |
| Mar 31, 2022 | -70,000.00 |
| Dec 31, 2021 | 3.42 Mn |
| Sep 30, 2021 | -4.20 Mn |
| Jun 30, 2021 | -30.12 Mn |